Project Summary


Thousands of genetic differences make everyone different. By studying genetic information, you can better treat the disease, choose better therapies, and understand the causes of cancer in someone's body at the most fundamental level. Clear Sky, a platform for gene big data company SaaS, has developed a cloud-based software platform to support genetics research. The mychro platform allows genetic experts to analyze data in patient DNA more efficiently, rather than spending time designing tools for researchers. The platform is designed to allow non-expert doctors to self-educate and perform some basic analysis. Clear Sky is currently completing a clinical trial study and will generate clinical information on platform performance by 2020.


•    Choose by Aginic Ventures to be one of the first companies to support and develop ²    Selected by ilab UQ Ventures, one of Australia's top accelerators;

•     Become a member of the famous BridgeTech pitch program;

•     Awarded at the BridgeTech pitch competition in Australia;

•     CEO Alan Robertson, as one of the 12 CEOs of Emerging Technologies, was invited to attend the NHS Roundtable and was personally praised by NHS Chairman Prior;

•     Selected by Queensland Life Sciences as a model of Queensland innovation


Team Profile


Alan Robertson,Founder & CEO

•    Genomics scientist with extensive genomics research experience ²    Used RNA-Seq in mammalian cell research and published books;


Robert McLeay PhD,Co-founder

•    Has extensive experience in software development;


Status of Technology and Business Maturity


Conducting clinical trials with local Australian collaborators